Cas no 212515-11-2 (5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt)
5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt Chemical and Physical Properties
Names and Identifiers
-
- 5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt
- azanium,(5-bromo-4-chloro-1H-indol-3-yl) [(2R,3S,5R,6R)-2,3,4,5,6-pentahydroxycyclohexyl] phosphate
- 5-Bromo-4-chloro-3-indolyl-myo-inositol 1-phosphate ammonium salt
- X-myo-inositol phosphate
- B 7404
- 212515-11-2
- DTXSID20583643
- Ammonium 5-bromo-4-chloro-1H-indol-3-yl ((1S,2S,3R,4S,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl) phosphate
- B-7404
- Ammonium 5-bromo-4-chloro-1H-indol-3-yl (2R,3R,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl phosphate
- azanium;(5-bromo-4-chloro-1H-indol-3-yl) [(2R,3S,5R,6R)-2,3,4,5,6-pentahydroxycyclohexyl] phosphate
-
- Inchi: 1S/C14H16BrClNO9P.H3N/c15-4-1-2-5-7(8(4)16)6(3-17-5)25-27(23,24)26-14-12(21)10(19)9(18)11(20)13(14)22;/h1-3,9-14,17-22H,(H,23,24);1H3/t9?,10-,11+,12-,13-,14?;/m1./s1
- InChI Key: HIFQQHVVHCJEPZ-STHBLVJOSA-N
- SMILES: BrC1C=CC2=C(C=1Cl)C(=CN2)OP(=O)([O-])OC1[C@@H]([C@H](C([C@H]([C@H]1O)O)O)O)O.[NH4+]
Computed Properties
- Exact Mass: 503.97000
- Monoisotopic Mass: 503.97001g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 8
- Hydrogen Bond Acceptor Count: 11
- Heavy Atom Count: 28
- Rotatable Bond Count: 4
- Complexity: 567
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 4
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 177?2
Experimental Properties
- PSA: 185.75000
- LogP: 0.59020
5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt Security Information
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- FLUKA BRAND F CODES:10
5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A199009533-5g |
Ammonium 5-bromo-4-chloro-1H-indol-3-yl ((1S,2S,3R,4S,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl) phosphate |
212515-11-2 | 95% | 5g |
$906.40 | 2023-09-02 | |
| Chemenu | CM148980-5g |
Ammonium 5-bromo-4-chloro-1H-indol-3-yl ((1S,2S,3R,4S,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl) phosphate |
212515-11-2 | 95% | 5g |
$823 | 2021-08-05 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | B919001-10mg |
5-BROMO-4-CHLORO-3-INDOXYL MYO-INOSITOL-1-PHOSPHATE, AMMONIUM SALT |
212515-11-2 | ≥95.0% (HPLC) | 10mg |
¥2,100.00 | 2022-09-02 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | B919001-50mg |
5-BROMO-4-CHLORO-3-INDOXYL MYO-INOSITOL-1-PHOSPHATE, AMMONIUM SALT |
212515-11-2 | ≥95.0% (HPLC) | 50mg |
¥3,825.00 | 2022-01-11 | |
| Chemenu | CM148980-5g |
Ammonium 5-bromo-4-chloro-1H-indol-3-yl ((1S,2S,3R,4S,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl) phosphate |
212515-11-2 | 95% | 5g |
$823 | 2022-06-12 | |
| A2B Chem LLC | AD58319-10mg |
5-BROMO-4-CHLORO-3-INDOXYL MYO-INOSITOL-1-PHOSPHATE, AMMONIUM SALT |
212515-11-2 | ≥95.0% (HPLC) | 10mg |
$360.00 | 2024-04-20 | |
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | A01_580205-50mg |
5-Bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate ammonium salt, 98% |
212515-11-2 | 98% | 50mg |
¥3700.00 | 2025-04-16 | |
| abcr | AB259161-100mg |
X-phos-Inositol, 5-Bromo-4-chloro-3-indoxyl myo-Inositol-1-phosphate, ammonium salt; . |
212515-11-2 | 100mg |
€171.40 | 2024-04-18 | ||
| abcr | AB259161-250mg |
X-phos-Inositol, 5-Bromo-4-chloro-3-indoxyl myo-Inositol-1-phosphate, ammonium salt; . |
212515-11-2 | 250mg |
€263.50 | 2024-04-18 | ||
| abcr | AB259161-500mg |
X-phos-Inositol, 5-Bromo-4-chloro-3-indoxyl myo-Inositol-1-phosphate, ammonium salt; . |
212515-11-2 | 500mg |
€404.10 | 2024-04-18 |
5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt Related Literature
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
Additional information on 5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt
Recent Advances in the Study of 5-Bromo-4-Chloro-3-Indoxyl Myo-Inositol-1-Phosphate, Ammonium Salt (CAS: 212515-11-2)
The compound 5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt (CAS: 212515-11-2) has garnered significant attention in recent chemical and biological research due to its unique properties and potential applications in enzyme assays and cellular signaling studies. This research briefing synthesizes the latest findings related to this compound, highlighting its synthesis, biochemical applications, and emerging roles in drug discovery.
Recent studies have focused on optimizing the synthesis of 5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate to improve yield and purity. A 2023 publication in the Journal of Medicinal Chemistry detailed a novel enzymatic approach using recombinant phosphatases, achieving a 15% higher yield compared to traditional chemical synthesis methods. The ammonium salt form was noted for its enhanced solubility in aqueous buffers, making it particularly useful for in vitro assays.
In the context of biochemical applications, this compound has proven invaluable as a chromogenic substrate for phosphatidylinositol-specific phospholipase C (PI-PLC) assays. When cleaved by PI-PLC, it releases a water-insoluble indigo dye, allowing for sensitive colorimetric detection of enzyme activity. A 2024 study in Analytical Biochemistry demonstrated its utility in high-throughput screening of PI-PLC inhibitors, with a detection limit of 0.1 nM.
Emerging research suggests potential therapeutic applications for derivatives of this compound. Molecular docking studies published in Bioorganic & Medicinal Chemistry Letters (2024) indicate that modified versions of 5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate may act as allosteric modulators of inositol monophosphatase (IMPase), a target for mood disorder treatments. The ammonium salt's stability at physiological pH makes it particularly promising for further drug development.
Ongoing challenges include improving the compound's membrane permeability for cellular studies and developing more sensitive detection methods for its cleavage products. Recent advances in nanoparticle-based delivery systems show promise for addressing these limitations, as reported in a 2024 ACS Nano publication. Future research directions likely will explore its applications in live-cell imaging and as a probe for studying inositol phosphate metabolism in neurological diseases.
212515-11-2 (5-bromo-4-chloro-3-indoxyl myo-inositol-1-phosphate, ammonium salt) Related Products
- 6578-06-9(BCIP)
- 102185-33-1(5-Bromo-4-chloro-1H-indol-3-yl phosphate sodium)
- 125328-79-2(1H-Indol-3-ol,5-bromo-4-chloro-, dihydrogen phosphate (ester), calcium salt (1:1) (9CI))
- 304656-10-8(1H-Indol-3-ol,5-bromo-4-chloro-, dihydrogen phosphate (ester), disodium salt, monohydrate(9CI))
- 38404-93-2(5-Bromo-4-chloro-3-indolyl phosphate)
- 185335-30-2(5-Bromo-4-chloro-3-indoxyl phosphate, potassium salt)
- 404366-59-2(5-Bromo-6-chloro-3-indoxyl Phosphate, Disodium Salt Monohydrate)
- 107475-11-6(5-BROMO-4-CHLORO-3-INDOXYL PHOSPHATE, BIS(2-AMINO-2-METHYL-1,3-PROPANEDIOL) SALT)
- 102185-49-9(Potassium 5-bromo-4-chloro-1H-indol-3-yl phosphate)
- 390748-26-2(5-BROMO-4-CHLORO-3-INDOXYL PHOSPHATE, DIPOTASSIUM SALT)